Natera
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
CEOStephen Leonard Chapman
CEOStephen Leonard Chapman
Employees4,434
Employees4,434
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded2003
Founded2003
Employees4,434
Employees4,434
NTRA Key Statistics
Market cap32.88B
Market cap32.88B
Price-Earnings ratio-103.60
Price-Earnings ratio-103.60
Dividend yield—
Dividend yield—
Average volume1.86M
Average volume1.86M
High today$239.15
High today$239.15
Low today$234.64
Low today$234.64
Open price$237.80
Open price$237.80
Volume1.45M
Volume1.45M
52 Week high$241.28
52 Week high$241.28
52 Week low$125.38
52 Week low$125.38
Stock Snapshot
With a market cap of 32.88B, Natera(NTRA) trades at $238.21. The stock has a price-to-earnings ratio of -103.60.
During the trading session on 2025-12-03, Natera(NTRA) shares reached a daily high of $239.15 and a low of $234.64. At a current price of $238.21, the stock is +1.5% higher than the low and still -0.4% under the high.
Trading activity shows a volume of 1.45M, compared to an average daily volume of 1.86M.
The stock's 52-week range extends from a low of $125.38 to a high of $241.28.
The stock's 52-week range extends from a low of $125.38 to a high of $241.28.
NTRA News
Simply Wall St 2d
Have Insiders Sold Natera Shares Recently?Some Natera, Inc. ( ) shareholders may be a little concerned to see that the Lead Independent Director, Roelof Botha, recently sold a substantial US$18m worth o...
Analyst ratings
90%
of 21 ratingsBuy
90.5%
Hold
9.5%
Sell
0%
People also own
Based on the portfolios of people who own NTRA. This list is generated using Robinhood data, and it’s not a recommendation.